Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ +1.97%66 Days Inventory is 106.72 as of Jun. 2026, which is 13% above its 10-year median of 94.71. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 2,971 Industrial Products companies, Medmix AG ranks better than 58.6% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Medmix AG's Average Total Inventories for the
six
months ended in Jun. 2026 was CHF78.0 Mil. Medmix AG's Cost of Goods Sold for the
six
months ended in Jun. 2026 was CHF133.3 Mil.
Hence, Medmix AG's Days Inventory for the
six
months ended in Jun. 2026 was 106.72.
The historical rank and industry rank for Medmix AG's Days Inventory or its related term are showing as below:
CHIX:MEDXz'
s Days Inventory Range Over the Past 10 Years
Min: 82.62 Med: 94.71 Max: 103.45
Current: 103.45
During the past 8 years, Medmix AG's highest Days Inventory was 103.45. The lowest was 82.62. And the median was 94.71.
CHIX:MEDXz's Days Inventory is ranked better than 58.6% of 2971
companies
in the Industrial Products industry
Industry Median: 119.96
vs CHIX:MEDXz: 103.45
Medmix AG's Days Inventory
increased
from Jun. 2025 (98.72) to Jun. 2026 (106.72).
It might indicate that Medmix AG's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medmix AG's Inventory Turnover for the
six
months ended in Jun. 2026 was 1.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medmix AG's Inventory-to-Revenue for the
six
months ended in Jun. 2026 was 0.36.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medmix AG's Inventory Turnover for the
six
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medmix AG's Inventory to Revenue for the
six
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medmix AG Days Inventory Related Terms
Medmix AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Medmix AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: Days Inventory Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Days Inventory vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medmix AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a Days Inventory of 106.72 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medmix AG and its competitors. This is 13% above median its historical median of 94.71. Over the past decade, Medmix AG's Days Inventory has ranged from 82.62 to 103.45. According to the industry distribution chart, Medmix AG ranks #1230 out of 2971 companies in the Industrial Products industry, placing it in the top 41.4%.
Is Medmix AG's Days Inventory too high?
Medmix AG's current Days Inventory of 106.72 is 13% above median its 10-year median of 94.71. Over the past 10 years, this metric has ranged from a low of 82.62 to a high of 103.45. The Industrial Products industry median Days Inventory is 119.96. Medmix AG's value of 106.72 is 11% below this industry median. Based on the distribution chart, Medmix AG ranks #1230 out of 2971 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Days Inventory compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1230 out of 2971 companies for Days Inventory. This puts Medmix AG in the upper half of its industry. The industry median Days Inventory is 119.96. Medmix AG's value of 106.72 is 11% below this benchmark. Historically, Medmix AG's own Days Inventory has ranged from 82.62 to 103.45 over the past decade. While the company's 10-year median is 94.71 vs. the industry median of 119.96, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for an Industrial Products company?
The median Days Inventory among Industrial Products companies is 119.96, based on 2,971 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current Days Inventory of 106.72 is 11% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Days Inventory is 119.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Days Inventory is 106.72, which is 13% above median its own 10-year median of 94.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Days Inventory is 106.72, which is 13% above median its 10-year median of 94.71 and 11% below the Industrial Products industry median of 119.96. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Days Inventory is 106.72 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
Days Inventory: 106.72 (13% above median its 10-year median of 94.71)
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
Industry Position: 11% below the Industrial Products median (#1230 of 2971)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
